Comparative open, randomized, cross-over bioequivalence study of two intravenous dexrazoxane formulations (Cardioxane and ICRF-187) in patients with advanced breast cancer, treated with 5-fluorouracil-doxorubicin-cyclophosphamide (FDC). (Q42605936)
Jump to navigation
Jump to search
scientific article published on January 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparative open, randomized, cross-over bioequivalence study of two intravenous dexrazoxane formulations (Cardioxane and ICRF-187) in patients with advanced breast cancer, treated with 5-fluorouracil-doxorubicin-cyclophosphamide (FDC). |
scientific article published on January 1999 |
Statements
1 reference
Comparative open, randomized, cross-over bioequivalence study of two intravenous dexrazoxane formulations (Cardioxane and ICRF-187) in patients with advanced breast cancer, treated with 5-fluorouracil-doxorubicin-cyclophosphamide (FDC). (English)
1 reference
Rosing H
1 reference
ten Bokkel Huinink WW
1 reference
van Gijn R
1 reference
Rombouts RF
1 reference
Bult A
1 reference
Beijnen JH
1 reference
1 January 1999
1 reference
1 reference
24
1 reference
1
1 reference
69-77
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference